ArticleJSES international2026
Failure mechanisms of the Exactech Equinoxe hybrid cage glenoid in anatomic TSA: a retrieval and radiographic case series.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glenoid loosening is a well-documented failure mechanism in anatomic shoulder arthroplasty. Implant manufacturers have developed innovative designs to address these issues, with hybrid glenoid components emerging as a potential solution. This study investigates the Exactech Equinoxe glenoid (Exactech Inc., Gainesville, FL, USA), a hybrid component that has shown higher midterm revision rates in national registry data. Methods: We conducted an investigation of failed Equinoxe Cage Glenoid implants revised between November 2022 and July 2025 and analyzed at a tertiary arthroplasty retrieval center. Clinical data, radiographs, and intraoperative findings were reviewed. Radiographs were assessed for radiolucency (Lazarus score), implant position, and evidence of fracture or metallic debris. Retrieved components underwent macroscopic inspection and evaluation of wear modes. Polyethylene (PE) oxidation was quantified through white-banding assessment and Fourier Transform Infrared Spectroscopy. Periprosthetic tissues, when available, underwent inductively coupled plasma mass spectrometry to evaluate metal ion presence. Results: Eleven failed hybrid glenoid components were analyzed at a median of 5.8 years after implantation. Radiographic loosening was present in 82% of cases (median Lazarus score 5). All retrieved components demonstrated macroscopic PE wear; 82% showed cracking and delamination. Fourier Transform Infrared Spectroscopy confirmed subsurface oxidation in all tested components. Peripheral peg fixation was limited, with 100% of pegs demonstrating minimal bony ongrowth and 45% showing polishing consistent with micromotion. In contrast, 100% of central metal cages exhibited bony ingrowth. Metal debris or staining was noted in 55% of cases, and tissue samples demonstrated elevated metal ions consistent with cage or peg wear. Conclusion: Failed Equinoxe Cage Glenoid implants demonstrated consistent patterns of PE oxidation and inadequate peripheral peg fixation, contributing to loosening and mechanical failure at the PE-metal interface. These findings provide a potential mechanism for the higher revision rate observed in national registry data and highlight the importance of ongoing postmarket surveillance of new implant designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.